HomeCompareFTMR vs MRK

FTMR vs MRK: Dividend Comparison 2026

FTMR yields 1211.39% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FTMR wins by $102253346.77M in total portfolio value
10 years
FTMR
FTMR
● Live price
1211.39%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102253346.83M
Annual income
$87,968,317,392,515.25
Full FTMR calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FTMR vs MRK

📍 FTMR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFTMRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FTMR + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FTMR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FTMR
Annual income on $10K today (after 15% tax)
$102,967.90/yr
After 10yr DRIP, annual income (after tax)
$74,773,069,783,637.95/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, FTMR beats the other by $74,773,069,775,041.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FTMR + MRK for your $10,000?

FTMR: 50%MRK: 50%
100% MRK50/50100% FTMR
Portfolio after 10yr
$51126673.44M
Annual income
$43,984,158,701,314.52/yr
Blended yield
86.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FTMR
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FTMR buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFTMRMRK
Forward yield1211.39%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$102253346.83M$57.7K
Annual income after 10y$87,968,317,392,515.25$10,113.78
Total dividends collected$101188738.72M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FTMR vs MRK ($10,000, DRIP)

YearFTMR PortfolioFTMR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$131,839$121,138.70$11,213$373.04+$120.6KFTMR
2$1,633,663$1,492,595.30$12,667$512.06+$1.62MFTMR
3$19,033,353$17,285,333.51$14,439$708.14+$19.02MFTMR
4$208,577,502$188,211,814.97$16,640$988.16+$208.56MFTMR
5$2,150,770,633$1,927,592,705.24$19,432$1,394.07+$2150.75MFTMR
6$20,877,578,197$18,576,253,619.93$23,057$1,992.90+$20877.56MFTMR
7$190,862,471,828$168,523,463,156.95$27,889$2,894.79+$190862.44MFTMR
8$1,644,072,088,539$1,439,849,243,683.72$34,518$4,286.29+$1644072.05MFTMR
9$13,350,494,797,864$11,591,337,663,126.59$43,912$6,494.35+$13350494.75MFTMR
10$102,253,346,826,229$87,968,317,392,515.25$57,714$10,113.78+$102253346.77MFTMR

FTMR vs MRK: Complete Analysis 2026

FTMRStock

Fortem Resources Inc. engages in the acquisition, exploration, and development of oil and gas properties in Canada and the United States. It holds 100% interest in the Godin property covering an area of approximately 12,800 located in the Godin area of Northern Alberta. The company also holds 75% interest in the Black Dragon property covering an area of 150,178 acres located in the Moenkopi formation of the Carbon and Emery Counties, Utah; and 75% interest in the Rolling Rock Property covering an area of 130,942 acres located in the Mancos formation in the Southern Uinta Basin, Utah. In addition, it holds 100% interest in the City of Gold mineral mining project in Myanmar. The company was formerly known as Strongbow Resources Inc. and changed its name to Fortem Resources Inc. in March 2017. Fortem Resources Inc. was founded in 2004 and is based in Calgary, Canada.

Full FTMR Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FTMR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FTMR vs SCHDFTMR vs JEPIFTMR vs OFTMR vs KOFTMR vs MAINFTMR vs JNJFTMR vs ABBVFTMR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.